HSD89 Impact of Race on Utilization of First Vs Second Generation Long-Acting Injectable Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1089
https://www.valueinhealthjournal.com/article/S1098-3015(22)01290-6/fulltext
Title :
HSD89 Impact of Race on Utilization of First Vs Second Generation Long-Acting Injectable Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01290-6&doi=10.1016/j.jval.2022.04.1089
First page :
Section Title :
Open access? :
No
Section Order :
10977